These findings suggest that etiology of tumor subtypes may vary by degree of pre-existing obesity of the patient and propose novel insights into molecular mechanisms linking obesity, ER expression, and proliferation to breast tumor development. The gene discussed is ESR1; the disease is obesity disorder.